Home » Topics » BioWorld Science

BioWorld Science
RSS

INBRX-130: a novel bispecific antibody targeting 5T4 and CD3

April 19, 2022

Anti-CLDN18.2/CD47 antibody PT-886 shows antitumoral activity in model of pancreatic cancer

April 19, 2022

New platform for rapid development of patient-specific APECs for ovarian carcinoma

April 19, 2022

IKZF2 degrader PLX-4107 shows promise as cancer immunotherapeutic

April 19, 2022

Insilico Medicine nominates USP1 small-molecule inhibitor as preclinical candidate

April 14, 2022

Inhaled CYB-004 shows advantages over intravenous and inhaled DMT

April 14, 2022

Artelo reports new preclinical data for GPCR agonist ART-27.13 for cancer-induced cachexia

April 14, 2022

SPK-001 demonstrates neutralization activity in vitro against SARS-CoV-2 variants of concern

April 14, 2022

VantAI and Janssen establish protein degrader discovery collaboration

April 14, 2022

AACR 2022: With ADCs established, branching out to irregular conjugation

April 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.